Marc E. Lippman is a scholar working on Molecular Biology, Oncology and Genetics.
According to data from OpenAlex, Marc E. Lippman has authored 413 papers receiving a total of 30.2k indexed citations (citations by other indexed papers that have themselves been cited), including 178 papers in Molecular Biology, 169 papers in Oncology and 162 papers in Genetics. Recurrent topics in Marc E. Lippman's work include Estrogen and related hormone effects (139 papers), HER2/EGFR in Cancer Research (53 papers) and Breast Cancer Treatment Studies (50 papers). Marc E. Lippman is often cited by papers focused on Estrogen and related hormone effects (139 papers), HER2/EGFR in Cancer Research (53 papers) and Breast Cancer Treatment Studies (50 papers). Marc E. Lippman collaborates with scholars based in United States, United Kingdom and Italy. Marc E. Lippman's co-authors include Robert B. Dickson, Karen Huff, E. Brad Thompson, Gail Bolan, Diane Bronzert, Joseph C. Allegra, Cornelius Knabbe, Attan Kasid, Robert Clarke and Barry I. Hudson and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.
In The Last Decade
Marc E. Lippman
406 papers
receiving
28.8k citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women
19991.4k citationsSteven R. Cummings, Stephen Eckert et al.profile →
Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells
Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial
2001505 citationsJane A. Cauley, Larry Norton et al.profile →
Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.
1990499 citationsMarc E. Lippman, C. Richter King et al.profile →
Targeting RAGE Signaling in Inflammatory Disease
2017395 citationsBarry I. Hudson, Marc E. Lippmanprofile →
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
Countries citing papers authored by Marc E. Lippman
Since
Specialization
Citations
This map shows the geographic impact of Marc E. Lippman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc E. Lippman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc E. Lippman more than expected).
This network shows the impact of papers produced by Marc E. Lippman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc E. Lippman. The network helps show where Marc E. Lippman may publish in the future.
Co-authorship network of co-authors of Marc E. Lippman
This figure shows the co-authorship network connecting the top 25 collaborators of Marc E. Lippman.
A scholar is included among the top collaborators of Marc E. Lippman based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Marc E. Lippman. Marc E. Lippman is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Xu, Liang, Dajun Yang, Shaomeng Wang, Wenhua Tang, & Marc E. Lippman. (2004). Gossypol(-), a potent small molecule inhibitor of Bcl-2/xl, improves response to radiation therapy and results in tumor regression of human prostate cancer. Cancer Research. 64. 959–959.1 indexed citations
9.
Kumar‐Sinha, Chandan, Kathleen Woods Ignatoski, Marc E. Lippman, Stephen P. Ethier, & Arul M. Chinnaiyan. (2003). Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis.. PubMed. 63(1). 132–9.180 indexed citations
Bacus, S S, Eliezer Huberman, D Chin, et al.. (1992). A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells.. PubMed. 3(7). 401–11.83 indexed citations
13.
King, C. Richter, Sandra M. Swain, Laura Porter, et al.. (1989). Heterogeneous expression of erbB-2 messenger RNA in human breast cancer.. PubMed. 49(15). 4185–91.56 indexed citations
Thompson, E. Brad & Marc E. Lippman. (1979). Steroid receptors and the management of cancer. CRC Press eBooks.15 indexed citations
16.
Lippman, Marc E., et al.. (1978). Clinical implications of glucocorticoid receptors in human leukemia.. PubMed. 38(11 Pt 2). 4251–6.90 indexed citations
17.
Allegra, Joseph C., Marc E. Lippman, E. Brad Thompson, & Richard Simon. (1978). An association between steroid hormone receptors and response to cytotoxic chemotherapy in patients with metastatic breast cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(11 Pt 2). 4299–304.27 indexed citations
18.
Lippman, Marc E.. (1977). Re: M. Lippman, G. Bolan, and K. Huff. Three Papers on Hormones and Breast Cancer in Vitro. Cancer Res., 36: 4595–4601, 4602–4609, 4610–4618, 1976.. Cancer Research. 37(9). 3465–3465.1 indexed citations
19.
Lippman, Marc E., Marie E. Monaco, & Gail Bolan. (1977). Effects of estrone, estradiol, and estriol on hormone-responsive human breast cancer in long-term tissue culture.. PubMed. 37(6). 1901–7.115 indexed citations
20.
Osborne, C. Kent, et al.. (1976). Insulin receptors in human breast cancer: relationship of binding, degradation and biological activity. Diabetes. 25.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.